Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GeneThera Inc (OTC Pink - Current Information:GTHR)

0.05
Delayed Data
As of Aug 24
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.09
+233.33%
Year-to-Date
SECTOR
Consumer Services
INDUSTRY
Publishing: Books/Magazines
MARKET CAP
$1.9M

Company Description

GeneThera, Inc. is a biotechnology company, which develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms that inhibit farm animals that potentially can transfer to humans through the food supply. It develops specific assays for chronic wasting disease among elk and deer and Mad Cow Disease among cattle, and Johne's disease and also develops therapeutics and vaccines for E.coli and Johne's disease. The company focus is on the diagnostic and treatment of Johne's disease. GeneThera was founded by Antonio Milici in November 1998 and is headquartered in Westminster, CO.

Contact Information

GeneThera, Inc.
9101 Harlan Street
Westminster Colorado 80031
P:(303) 439-2085
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Antonio MiliciChairman, President & Chief Executive Officer
Tannya L. IrizarryChief Financial & Administrative Officer